Literature DB >> 17397238

Effects of pH and polyanions on the thermal stability of fibroblast growth factor 20.

Haihong Fan1, Samadhi N Vitharana, Tracy Chen, Donald O'Keefe, C Russell Middaugh.   

Abstract

Fibroblast growth factor 20 (FGF20) is a member of the FGF family with potential for use in several different therapeutic categories. In this work, we provide the first structural characterization of FGF20 using a wide variety of approaches. Like other members of the FGF family, FGF20 appears to possess a beta-trefoil structure. The effect of pH on the conformation and thermal stability of FGF20 is evaluated using far-UV circular dichroism (CD), intrinsic and ANS fluorescence, and high-resolution derivative UV absorption spectroscopy. Empirical phase diagrams are constructed to describe the solution behavior of FGF20 over a wide pH and temperature range. The protein appears to be unstable at pH <5, with aggregation and precipitation observed during dialysis. A major heat-induced conformational change also causes aggregation and precipitation of FGF20 at elevated temperatures. The highest thermal stability is observed near neutral pH (Tm ~55 degrees C at pH 7). The effect of several high- and low-molecular mass polyanions on the thermal stability of FGF20 is also examined using CD, intrinsic fluorescence, and DSC analysis. Among these ligands, heparin exhibits the greatest stabilizing effect on FGF20, increasing the Tm by more than 10 degrees C.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397238     DOI: 10.1021/mp060097h

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  13 in total

1.  Mapping site-specific changes that affect stability of the N-terminal domain of calmodulin.

Authors:  Mary E Krause; Talia T Martin; Jennifer S Laurence
Journal:  Mol Pharm       Date:  2012-02-15       Impact factor: 4.939

Review 2.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

3.  Application of fluorescence spectroscopy to quantify shear-induced protein conformation change.

Authors:  Efrosyni Themistou; Indrajeet Singh; Chengwei Shang; Sathy V Balu-Iyer; Paschalis Alexandridis; Sriram Neelamegham
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

Review 4.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part I: recapitulation of native tissue healing and variables for the design of delivery systems.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-02-19       Impact factor: 6.389

Review 5.  Multidimensional methods for the formulation of biopharmaceuticals and vaccines.

Authors:  Nathaniel R Maddux; Sangeeta B Joshi; David B Volkin; John P Ralston; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2011-06-06       Impact factor: 3.534

6.  Influence of the valine zipper region on the structure and aggregation of the basic leucine zipper (bZIP) domain of activating transcription factor 5 (ATF5).

Authors:  Natalie A Ciaccio; T Steele Reynolds; C Russell Middaugh; Jennifer S Laurence
Journal:  Mol Pharm       Date:  2012-10-23       Impact factor: 4.939

7.  The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study.

Authors:  Lu Liu; Wei Qi; Daniel K Schwartz; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2013-05-27       Impact factor: 3.534

8.  Controlled release of repifermin from polyelectrolyte complexes stimulates endothelial cell proliferation.

Authors:  Min Huang; Cory Berkland
Journal:  J Pharm Sci       Date:  2009-01       Impact factor: 3.534

9.  Biophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.

Authors:  Sumin Cai; Feng He; Hardeep S Samra; Luis M de la Maza; Maria E Bottazzi; Sangeeta B Joshi; C Russell Middaugh
Journal:  Mol Pharm       Date:  2009 Sep-Oct       Impact factor: 4.939

10.  Deficiency of zebrafish fgf20a results in aberrant skull remodeling that mimics both human cranial disease and evolutionarily important fish skull morphologies.

Authors:  W James Cooper; Rachel M Wirgau; Elly M Sweet; R Craig Albertson
Journal:  Evol Dev       Date:  2013 Nov-Dec       Impact factor: 1.930

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.